Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)
Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.
Tags : GLENMARK PHARMACEUTICALS INC FOREST LABORATORIES LLC FOREST LABORATORIES HOLDINGS ROYALTY PHARMA COLLECTION TRUST
Share :
|